Before Elizabeth Holmes promised to revolutionize blood testing, another charismatic CEO was using identical tactics to convince investors she'd cracked the code on personalized skincare. Meet Madison Reed's Amy Errett and the beauty startup that raised $140 million by promising custom formulas that its own scientists knew were mostly marketing theater.